Febarbamate

This classification denotes an anticonvulsant agent with the molecular formula C20H27N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5Z48ONN38P, chemically known as 1-(3-butoxy-2-hydroxypropyl)-5-ethyl-5-phenylbarbituric acid, carbamate ester but generally known as febarbamate, which bears US NIH Compound Identifier 25803. European Medicines Agency schedules Febarbamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07519MIG. The term FEBARBAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules febarbamate in its Anatomical Therapeutic Chemical (ATC) Classification. FEBARBAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule febarbamate under HS 29335400 and SITC kg. As of Q4 2014, FEBARBAMATE remains the US FDA Preferred Term for this commodity. Febarbamate bears US NLM identifiers UMLS ID C0060130 and NCI Concept Code C65626. SMILES: O=C1N(CC(OC(=O)N)COCCCC)C(=O)NC(=O)C1(CC)c1ccccc1.